1 | GSM685446 | RNA isolated from PBMCs (Micro1) | gender: Male | creatinine clearance: >90 ml/min/1.73 m2 body surface area (evaluated by Cockcroft-Gault formula) | serum creatinine: <1.2 mg/dl | clinical follow up: At least 7 years | disease state: IgA nephropathy | disease stage: macroscopic hematuria | patient: 1 | cell type: PBMC |
2 | GSM685452 | RNA isolated from PBMCs (Micro2) | gender: Female | creatinine clearance: >90 ml/min/1.73 m2 body surface area (evaluated by Cockcroft-Gault formula) | serum creatinine: <1.2 mg/dl | clinical follow up: At least 7 years | disease state: IgA nephropathy | disease stage: macroscopic hematuria | patient: 2 | cell type: PBMC |
3 | GSM685454 | RNA isolated from PBMCs (Micro3) | gender: Male | creatinine clearance: >90 ml/min/1.73 m2 body surface area (evaluated by Cockcroft-Gault formula) | serum creatinine: <1.2 mg/dl | clinical follow up: At least 7 years | disease state: IgA nephropathy | disease stage: macroscopic hematuria | patient: 3 | cell type: PBMC |
1 | GSM685451 | RNA isolated from PBMCs (MACRO1) | gender: Male | creatinine clearance: >90 ml/min/1.73 m2 body surface area (evaluated by Cockcroft-Gault formula) | serum creatinine: <1.2 mg/dl | clinical follow up: At least 7 years | disease state: IgA nephropathy | disease stage: microscopic hematuria | patient: 1 | cell type: PBMC |
2 | GSM685453 | RNA isolated from PBMCs (MACRO2) | gender: Female | creatinine clearance: >90 ml/min/1.73 m2 body surface area (evaluated by Cockcroft-Gault formula) | serum creatinine: <1.2 mg/dl | clinical follow up: At least 7 years | disease state: IgA nephropathy | disease stage: microscopic hematuria | patient: 2 | cell type: PBMC |
3 | GSM685455 | RNA isolated from PBMCs (MACRO3) | gender: Male | creatinine clearance: >90 ml/min/1.73 m2 body surface area (evaluated by Cockcroft-Gault formula) | serum creatinine: <1.2 mg/dl | clinical follow up: At least 7 years | disease state: IgA nephropathy | disease stage: microscopic hematuria | patient: 3 | cell type: PBMC |